Literature DB >> 16386657

Role of diminished renal function in cardiovascular mortality: marker or pathogenetic factor?

Robert W Schrier1.   

Abstract

The interactions between the heart and the kidney recently have been the focus of intense interest because of epidemiological evidence indicating that even mild deterioration of renal function is an important risk factor for poor outcome in patients with congestive heart failure, myocardial infarction, and cardiovascular surgery. Kidney function deterioration may be a consequence of cardiac and baroreceptor dysfunction or may be primarily caused by intrinsic kidney disease. This review provides a comprehensive analysis of the role of the kidney not only as a marker but also as a pathogenic factor in cardiorenal syndromes, whether primary heart or primary kidney disease or both are the initiators of the subsequent pathophysiological events.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16386657     DOI: 10.1016/j.jacc.2005.07.067

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN: 0735-1097            Impact factor:   24.094


  77 in total

1.  Heart failure with a normal ejection fraction: treatments for a complex syndrome?

Authors:  Samuel Bernard; Mathew S Maurer
Journal:  Curr Treat Options Cardiovasc Med       Date:  2012-08

2.  What have we learned about loop diuretics in acute decompensated heart failure? The DOSE trial.

Authors:  Dmitry Shchekochikhin; JoAnn Lindenfeld
Journal:  Curr Cardiol Rep       Date:  2012-06       Impact factor: 2.931

3.  Ultrafiltration in patients with decompensated heart failure and diuretic resistance: an Asian centre's experience.

Authors:  Loon Yee Louis Teo; Choon Pin Lim; Chia Lee Neo; Lee Wah Teo; Swee Ling Elaine Ng; Laura Lihua Chan; Manish Kaushik; Kheng Leng David Sim
Journal:  Singapore Med J       Date:  2016-01-15       Impact factor: 1.858

4.  Impact of onset time of acute kidney injury on outcomes in patients with acute decompensated heart failure.

Authors:  Yoichi Takaya; Fumiki Yoshihara; Hiroyuki Yokoyama; Hideaki Kanzaki; Masafumi Kitakaze; Yoichi Goto; Toshihisa Anzai; Satoshi Yasuda; Hisao Ogawa; Yuhei Kawano
Journal:  Heart Vessels       Date:  2014-08-24       Impact factor: 2.037

5.  Cardiac Resynchronization Therapy in CKD Stage 4 Patients.

Authors:  Ulas Höke; Mand J H Khidir; Enno T van der Velde; Martin J Schalij; Jeroen J Bax; Victoria Delgado; Nina Ajmone Marsan
Journal:  Clin J Am Soc Nephrol       Date:  2015-09-25       Impact factor: 8.237

Review 6.  Treatment of congestion in heart failure with diuretics and extracorporeal therapies: effects on symptoms, renal function, and prognosis.

Authors:  Maria Rosa Costanzo; Mariell Jessup
Journal:  Heart Fail Rev       Date:  2012-03       Impact factor: 4.214

7.  Comorbid Heart Failure and Renal Impairment: Epidemiology and Management.

Authors:  Pupalan Iyngkaran; Merlin Thomas; William Majoni; Nagesh S Anavekar; Claudio Ronco
Journal:  Cardiorenal Med       Date:  2012-10-31       Impact factor: 2.041

Review 8.  Relaxin, a pleiotropic vasodilator for the treatment of heart failure.

Authors:  Sam L Teichman; Elaine Unemori; Thomas Dschietzig; Kirk Conrad; Adriaan A Voors; John R Teerlink; G Michael Felker; Marco Metra; Gad Cotter
Journal:  Heart Fail Rev       Date:  2008-12-20       Impact factor: 4.214

9.  Increased mortality among survivors of myocardial infarction with kidney dysfunction: the contribution of gaps in the use of guideline-based therapies.

Authors:  Pamela N Peterson; Amrut V Ambardekar; Philip G Jones; Harlan M Krumholz; Erik Schelbert; John A Spertus; John S Rumsfeld; Frederick A Masoudi
Journal:  BMC Cardiovasc Disord       Date:  2009-07-08       Impact factor: 2.298

10.  Progression of renal dysfunction in patients with cardiovascular disease.

Authors:  Yasunobu Hirata; Arihiro Kiyosue; Masao Takahashi; Hiroshi Satonaka; Daisuke Nagata; Masataka Sata; Etsu Suzuki; Ryozo Nagai
Journal:  Curr Cardiol Rev       Date:  2008-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.